ex vivo therapy

ex vivo therapy

Molecular medicine A therapy in which cells or genes are modified out of the body and reintroduced into a person with a genetic disease. See Gene therapy.
Mentioned in ?
References in periodicals archive ?
NaPro is currently developing an ex vivo therapy for sickle cell disease based upon NaPro's proprietary gene editing technology which addresses the underlying genetic basis of the disease.
Potential therapeutic applications of TCC technology include ex vivo therapy for otherwise intractable conditions, such as severe infections in immunocompromised patients, and therapy of cancer.
Ex vivo therapy involves utilizing certain cells from the patient's blood or from other donor sources, pulsing them with PSMA, and returning them to the patient so that the immune system will mount a response against the cancerous cells which contain PSMA on their surface.
If this evaluation is successful, IDM will be granted an exclusive license with Nemod in the field of ex vivo therapy, allowing IDM to further develop and commercialize several new products to fight cancers such as colon, gastric, breast, prostate and ovarian cancer.